Amino Alcohol- (NPS-2143) and Quinazolinone-Derived Calcilytics (ATF936 and AXT914) Differentially Mitigate Excessive Signalling of Calcium-Sensing Receptor Mutants Causing Bartter Syndrome Type 5 and Autosomal Dominant Hypocalcemia
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Amino Alcohol- (NPS-2143) and Quinazolinone-Derived Calcilytics (ATF936 and AXT914) Differentially Mitigate Excessive Signalling of Calcium-Sensing Receptor Mutants Causing Bartter Syndrome Type 5 and Autosomal Dominant Hypocalcemia
Authors
Keywords
-
Journal
PLoS One
Volume 9, Issue 12, Pages e115178
Publisher
Public Library of Science (PLoS)
Online
2014-12-16
DOI
10.1371/journal.pone.0115178
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- AXT914 a novel, orally-active parathyroid hormone-releasing drug in two early studies of healthy volunteers and postmenopausal women
- (2014) Markus R. John et al. BONE
- CaSR function in the intestine: Hormone secretion, electrolyte absorption and secretion, paracrine non-canonical Wnt signaling and colonic crypt cell proliferation
- (2013) R. John MacLeod BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- Calcium Sensing Receptor Absence Delays Postnatal Brain Development via Direct and Indirect Mechanisms
- (2013) Xiu-Ling Liu et al. MOLECULAR NEUROBIOLOGY
- Mutations Affecting G-Protein Subunit α11 in Hypercalcemia and Hypocalcemia
- (2013) M. Andrew Nesbit et al. NEW ENGLAND JOURNAL OF MEDICINE
- Identification and characterization of D410E, a novel mutation in the loop 3 domain of CASR, in autosomal dominant hypocalcemia and a therapeutic approach using a novel calcilytic, AXT914
- (2012) So Young Park et al. CLINICAL ENDOCRINOLOGY
- Recombinant Human Parathyroid Hormone Therapy (1-34) in an Adult Patient with a Gain-of-Function Mutation in the Calcium-Sensing Receptor—A Case Report
- (2012) Michael Gonzales et al. Endocrine Practice
- Identification of Molecular Phenotypes and Biased Signaling Induced by Naturally Occurring Mutations of the Human Calcium-Sensing Receptor
- (2012) Katie Leach et al. ENDOCRINOLOGY
- Two novel mutations of the calcium-sensing receptor gene affecting the same amino acid position lead to opposite phenotypes and reveal the importance of p.N802 on receptor activity
- (2012) Anne-Sophie Lia-Baldini et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Activating mutations in the calcium-sensing receptor: genetic and clinical spectrum in 25 patients with autosomal dominant hypocalcaemia - a German survey
- (2011) Friedhelm Raue et al. CLINICAL ENDOCRINOLOGY
- The Calcium-Sensing Receptor: A Molecular Perspective
- (2011) Aaron L. Magno et al. ENDOCRINE REVIEWS
- Calcilytics: antagonists of the calcium-sensing receptor for the treatment of osteoporosis
- (2011) Leo Widler Future Medicinal Chemistry
- Novel Activating Mutations of the Calcium-Sensing Receptor: The Calcilytic NPS-2143 Mitigates Excessive Signal Transduction of Mutant Receptors
- (2010) Saskia Letz et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Hypercalcaemic and hypocalcaemic conditions due to calcium-sensing receptor mutations
- (2008) Ogo I. Egbuna et al. BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
- PTH(1-34) Replacement Therapy in a Child With Hypoparathyroidism Caused by a Sporadic Calcium Receptor Mutation
- (2008) Todd A Theman et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Novel Inactivating Mutations of the Calcium-Sensing Receptor: The Calcimimetic NPS R-568 Improves Signal Transduction of Mutant Receptors
- (2008) Ramona Rus et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now